A Study of DCR-STAT3 in Adults With Solid Tumors

Clinical trial NCT06098651 · COMPLETED

Trial details

NCT number: NCT06098651
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Refractory Tumor

Start date: 2023-08-14
Primary completion: 2025-09-17
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.